Skip to main content
Signal8
Launch Terminal
Zuraw Qing Che profile photo

Qing Che Zuraw

CIK: 0002079210

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Vor Biopharma Inc. logo
VOR

Vor Biopharma Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Dec 5, 2025
    Disposition(D)

    Employee Stock Option (right to buy)

    Direct
    218.7K shares-
  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Dec 5, 2025
    Award(A)

    Employee Stock Option (right to buy)

    Direct
    218.7K shares-
  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Jul 17, 2025
    Award(A)
    Direct
    937.1K shares-

1-3 of 3

About Zuraw Qing Che

Zuraw Qing Che (SEC CIK 0002079210) files insider reports with the SEC as Chief Development Officer of Vor Biopharma Inc. (VOR).

Signal8 holds 3 ownership filings by Zuraw Qing Che (1 Form 3, 2 Form 4), filed between Jul 30, 2025 and Dec 9, 2025. Those filings report 3 transactions, from Jul 17, 2025 to Dec 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Zuraw Qing Che's filings is in CAMBRIDGE, MA.

Recent filings by Zuraw Qing Che

  • Dec 5, 2025: Disposition to issuer transaction of VOR derivative securities (Form 4, code D).
  • Dec 5, 2025: Grant or award of VOR derivative securities (Form 4, code A).
  • Jul 17, 2025: Grant or award of VOR shares (Form 4, code A).

Other insiders filing for Vor Biopharma Inc. (VOR)

How to read Form 4 transaction codes